Clinical Trial Update: Hyperalgesia, Persistent Pain, and Fentanyl Dosing in On-Pump Coronary Artery Bypass Grafting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating hyperalgesia, persistent pain, and fentanyl dosing in on-pump coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperalgesia
• Pain
• Postoperative Pain

Drugs mentioned

• FENTANYL (FENTANYL)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Hyperalgesia, Opioid Use | Phase 4 | Status: COMPLETED